MENU

INTS Intensity Therapeutics Forecast, Technical & Fundamental Analysis

Industry Biotechnology
INTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
INTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

INTS is expected to report earnings to fall 10.00% to -22 cents per share on March 13

Intensity Therapeutics INTS Stock Earnings Reports
Q4'24
Est.
$-0.22
Q3'24
Beat
by $0.06
Q2'24
Missed
by $0.04
Q4'23
Missed
by $0.05
Q3'23
Missed
by $0.08
The last earnings report on November 13 showed earnings per share of -25 cents, beating the estimate of -30 cents. With 16.32K shares outstanding, the current market capitalization sits at 30.52M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1 Enterprise Drive
Phone
+1 203 221-7381
Employees
17
Web
https://www.intensitytherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

INTS and Stocks

Correlation & Price change

A.I.dvisor tells us that INTS and CKPT have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INTS and CKPT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INTS
1D Price
Change %
INTS100%
-1.72%
CKPT - INTS
32%
Poorly correlated
+9.59%
SYRE - INTS
31%
Poorly correlated
+3.44%
GBIO - INTS
29%
Poorly correlated
-6.03%
CARA - INTS
29%
Poorly correlated
-3.22%
MNKD - INTS
29%
Poorly correlated
-5.42%
More